Clinical Study

Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial

Table 3

Average daily drug dose and percentage on titrated doses for diabetes agents and statins by sex.

AgentAverage daily dose (mg)% on titrated dose
FemaleMaleFemaleMale valueThresholdFemaleMale value

Taking diabetes drug6221465Diabetes drugs72%73%0.63
Any insulin sensitizing 3941015 IS58%62%0.27
 TZD111322  TZD46%42%0.46
  Pioglitazone6113932.531.30.49   >30 mg36%32%0.54
  Rosiglitazone501836.76.00.12   >4 mg58%50%0.30
 Metformin3449071517.51526.20.83   >1000 mg58%61%0.31
Any insulin providing 5151162 IP71%69%0.34
 Sulfonylurea 316864  SU63%64%0.66
  Glyburide19254018.013.50.30   >5 mg75%73%0.58
  Glipizide8723617.614.00.31   >10 mg31%44%0.03
  Glimepiride37885.14.30.17   >2 mg76%66%0.28
 Insulin2493970.7 unit/kg0.6 unit/kg 0.17   >0.4 unit/kg75%68%0.04
Taking statin 4831186Statins46%46%0.96
 Atorvastatin18144329.425.00.01 >10 mg66%62%0.36
 Lovastatin164228.835.50.18 >20 mg38%64%0.07
 Pravastatin419232.924.80.002 >40 mg5%1%0.17
 Simvastatin24560928.829.80.53 >20 mg39%41%0.71

IS = insulin sensitizing; IP = insulin providing diabetes drugs; SU = sulfonylurea.